Ads
related to: BioNTech and Vaccine
Search results
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 1 week agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 2 weeks agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 2 weeks agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
What's Going With BioNTech Stock On Monday?
Benzinga· 1 week agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 2 weeks agoIt simply wasn’t affordable for the plans for a new plant to go ahead – something experts have...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 1 week agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...
The true tragedy of the Covid-19 vaccines
Daily Telegraph· 2 weeks agoIndeed, some public health officials exaggerated the benefits and underplayed some of the risks. Thrombosis caused by the AstraZeneca vaccine and ...
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 4 days agoIn the first year, vaccinations were estimated to have prevented 19.8 million COVID-19 deaths...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 1 week agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
BMO Capital cuts BioNTech stock target, keeps Outperform By Investing.com
Investing.com· 7 days agoOn Tuesday, BMO Capital Markets adjusted its price target for shares of BioNTech (NASDAQ:BNTX), a...